Literature DB >> 16757774

Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature.

Angelo Salerno1, Robert Hermann.   

Abstract

Despite the availability of various analgesic regimens, patient surveys have indicated that moderate-to-severe postoperative pain is still poorly managed. The use of corticosteroids for postoperative pain relief, although popular, has yet to gain wider acceptance because of concerns over side effects, in particular adrenal suppression, osteonecrosis, impaired wound-healing, and concerns about efficacy. The medical literature provides evidence that should substantially decrease these concerns with regard to low and short-dose applications. The results of randomized trials have shown low, short-dose corticosteroid regimens to be safe and effective for reducing postoperative pain. There is strong, grade-A evidence supporting the use of corticosteroids in multimodal analgesia protocols to contribute to the postoperative recovery of the patient by minimizing opioid doses and therefore side effects. However, the optimal mode, dose, and timing of administration remain unclear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757774     DOI: 10.2106/JBJS.D.03018

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  44 in total

1.  Pre-operative corticosteroid injections improve functional outcomes in patients undergoing arthroscopic repair of high-grade partial-thickness rotator cuff tears.

Authors:  Nicholas K Donohue; Anthony R Prisco; Steven I Grindel
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10

2.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  Effect of intravenous methylprednisolone on pain after intertrochanteric femoral fracture surgery.

Authors:  Poupak Rahimzadeh; Farnad Imani; Seyed Hamid Reza Faiz; Nasim Nikoubakht; Azadeh Sayarifard
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 4.  Perioperative systemic glucocorticoids in total hip and knee arthroplasty: A systematic review of outcomes.

Authors:  Jeffrey Hartman; Vickas Khanna; Anthony Habib; Forough Farrokhyar; Muzammil Memon; Anthony Adili
Journal:  J Orthop       Date:  2017-04-12

5.  Methylprednisolone reduces pain and decreases knee swelling in the first 24 h after fast-track unicompartmental knee arthroplasty.

Authors:  Søren Rytter; Maiken Stilling; Stig Munk; Torben Bæk Hansen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-01-07       Impact factor: 4.342

6.  Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study.

Authors:  Bin Xu; Jun Ma; Qiang Huang; Ze-Yu Huang; Shao-Yun Zhang; Fu-Xing Pei
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-05-04       Impact factor: 4.342

7.  Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial.

Authors:  Merle N Tandoc; Liang Fan; Sergei Kolesnikov; Alexander Kruglov; Nader D Nader
Journal:  J Anesth       Date:  2011-06-17       Impact factor: 2.078

8.  Effect of Intraoperative Dexamethasone on Pain Scores and Narcotic Consumption in Patients Undergoing Total Knee Arthroplasty.

Authors:  Jason Samona; Carrie Cook; Kyle Krupa; Krystle Swatsell; Andrew Jackson; Chase Dukes; Sidney Martin
Journal:  Orthop Surg       Date:  2017-03-15       Impact factor: 2.071

9.  Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome : A prospective randomized study of functional outcomes.

Authors:  M Aksakal; C Ermutlu; G Özkaya; Y Özkan
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

10.  Preemptive multimodal analgesia for postoperative pain management after lumbar fusion surgery: a randomized controlled trial.

Authors:  Sang-Il Kim; Kee-Yong Ha; In-Soo Oh
Journal:  Eur Spine J       Date:  2015-09-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.